<--- Back to Details
First PageDocument Content
Antivirals / Protease inhibitors / Hepatitis / Infectious diseases / Cytokines / Telaprevir / Hepatitis C and HIV co-infection / Interferon / Boceprevir / Medicine / Biology / Health
Date: 2013-03-06 00:10:49
Antivirals
Protease inhibitors
Hepatitis
Infectious diseases
Cytokines
Telaprevir
Hepatitis C and HIV co-infection
Interferon
Boceprevir
Medicine
Biology
Health

Microsoft Word - Revised hep c info 2013.doc

Add to Reading List

Source URL: www.hepatitisfoundation.org

Download Document from Source Website

File Size: 330,91 KB

Share Document on Facebook

Similar Documents

Acute Hepatitis C in the PROUD pilot study Juan Tiraboschi, Liz Brodnicki, Brady Michael, John Saunders, Schembri Gabriel, Mark Roche, Julie Fox on behalf of the PROUD study

DocID: 1vngt - View Document

PRESS RELEASE AbbVie Receives Health Canada Approval of HOLKIRATM PAK for the Treatment of Chronic Genotype 1 Hepatitis C  New all-oral, short-course (12 weeks), interferon-free treatment available in Canada for geno

DocID: 1vlwz - View Document

PRESS RELEASE AbbVie’s MAVIRET™ Approved by Health Canada for the Treatment of Chronic Hepatitis C in All Major Genotypes   

DocID: 1vjI2 - View Document

APASL and CEVHAP Partnership: a Hepatitis-Free World November

DocID: 1vgwC - View Document

California Institute of Technology Hepatitis B Vaccination Offer Form Occupational Exposure to Bloodborne Pathogens Please complete this form if you may come in contact with human blood or other potentially infectious hu

DocID: 1vf93 - View Document